Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
Hs 578T | Ulixertinib | 0.1 | 0.7224 | 0.08812 |
Hs 578T | Ulixertinib | 3.16227766 | 0.4149 | 0.28956 |
Hs 578T | Ulixertinib | 0.01 | 0.8715 | 0.01652 |
Hs 578T | Ulixertinib | 0.1 | 0.7405 | 0.07292 |
Hs 578T | Ulixertinib | 1.0 | 0.6000 | 0.11074 |
Hs 578T | Ulixertinib | 3.16227766 | 0.4106 | 0.16591 |
Hs 578T | Ulixertinib | 0.001 | 0.9411 | 0.00431 |
Hs 578T | Ulixertinib | 0.003162278 | 0.8950 | 0.05362 |
Hs 578T | Ulixertinib | 0.031622777 | 0.6911 | 0.13153 |
Hs 578T | Ulixertinib | 0.1 | 0.7351 | 0.08334 |
Hs 578T | Ulixertinib | 0.316227766 | 0.5371 | 0.09653 |
Hs 578T | Ulixertinib | 0.316227766 | 0.5650 | 0.15225 |
Hs 578T | Ulixertinib | 1.0 | 0.5758 | 0.16473 |
Hs 578T | Ulixertinib | 1.0 | 0.5718 | 0.14057 |
Hs 578T | Ulixertinib | 0.001 | 0.9987 | 0.00368 |
Hs 578T | Ulixertinib | 0.001 | 1.0086 | 0.03848 |
Hs 578T | Ulixertinib | 0.003162278 | 0.9127 | 0.01667 |
Hs 578T | Ulixertinib | 0.003162278 | 0.9744 | 0.02367 |
Hs 578T | Ulixertinib | 0.01 | 0.9015 | 0.05635 |
Hs 578T | Ulixertinib | 0.01 | 0.8638 | 0.01926 |
Hs 578T | Ulixertinib | 0.031622777 | 0.8413 | 0.07445 |
Hs 578T | Ulixertinib | 0.031622777 | 0.7545 | 0.08620 |
Hs 578T | Ulixertinib | 0.316227766 | 0.5846 | 0.13159 |
Hs 578T | Ulixertinib | 10.0 | 0.2515 | 0.04996 |
Hs 578T | Ulixertinib | 3.16227766 | 0.3741 | 0.12467 |